-+ 0.00%
-+ 0.00%
-+ 0.00%

Macquarie Maintains Outperform on Core Scientific, Lowers Price Target to $28

Benzinga·03/04/2026 19:48:17
Listen to the news
Macquarie analyst Paul Golding maintains Core Scientific (NASDAQ:CORZ) with a Outperform and lowers the price target from $34 to $28.